Pregene
Pingshan
About Pregene
Pregene is a drug and nano-antibody drug biotechnology research and development platform.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 101 – 250
- Total funding: $4.5M
- Funding stage: Early Stage Venture
- Last round: Series A (May 2018)
- Website: pregene.com
- Phone: +86 400-881-8481
Industries & Categories
Biotechnology, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/pregene-97297 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.